ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,08165
0,00%
Bitcoin
69.328,12
-0,01%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Sarepta Therapeutics Inc New (SRPT)

  7. Sarepta Therapeutics Inc New (SRPT) News

SRPT

Sarepta Therapeutics (SRPT)

Sarepta Therapeutics Inc New
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SRPT
DatumZeitQuelleÜberschriftSymbolFirma
07/06/202422h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRPTSarepta Therapeutics Inc New
07/06/202419h30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SRPTSarepta Therapeutics Inc New
31/05/202423h45Business WireSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SRPTSarepta Therapeutics Inc New
29/05/202423h48PR Newswire (US)Sarepta Therapeutics Set to Join S&P MidCap 400NASDAQ:SRPTSarepta Therapeutics Inc New
07/05/202402h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
07/05/202402h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
03/05/202416h07Business WireGene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global HealthNASDAQ:SRPTSarepta Therapeutics Inc New
01/05/202422h05Business WireSarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate DevelopmentsNASDAQ:SRPTSarepta Therapeutics Inc New
01/05/202400h38Business WireSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SRPTSarepta Therapeutics Inc New
24/04/202414h30Business WireSarepta Therapeutics to Announce First Quarter 2024 Financial ResultsNASDAQ:SRPTSarepta Therapeutics Inc New
29/03/202421h00Business WireSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SRPTSarepta Therapeutics Inc New
08/03/202423h38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
07/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
07/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
07/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
07/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
07/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
06/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
06/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
06/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
06/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
06/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
06/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
06/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
06/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
06/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
06/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
06/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
05/03/202423h34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SRPTSarepta Therapeutics Inc New
04/03/202414h30Business WireSarepta Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:SRPTSarepta Therapeutics Inc New
 Showing the most relevant articles for your search:NASDAQ:SRPT

Kürzlich von Ihnen besucht

USOTC
TBNNY
Tamboran Resources (PK)
BIT
UB592L
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten